MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

BioScience Health Innovations, Inc. (BHIC)

BioScience Health Innovations, Inc. (BHIC)

|||

Balance Sheets Overview

Debt to Asset Ratio
14.10%
Unit: Dollar
Assets Breakdown
    • Inventory
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Note payable - related party
    • Accumulated earnings (deficit)
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
712,378
1,145,005
661,925
1,139,423
Accounts receivable, net
396,899
78,278
399,257
63,212
Income tax receivable
34,992
-
-
-
Operating digital assets
4,500
-
-
-
Inventory
797,183
874,340
336,348
757,500
Prepaid expense
40,961
95,146
21,341
34,864
Overpayment to related parties
0
0
137,718
0
Deferred tax asset
0
2,069
2,069
-
Total current assets
1,986,913
2,194,838
1,558,658
1,994,999
Intangible assets
109,845
82,887
82,887
72,101
Deposits
4,400
4,400
4,400
-
Right-of-use asset
34,992
48,114
61,236
-
Total other assets
149,237
135,401
148,523
-
Total assets
2,136,150
2,330,239
1,707,181
2,067,100
Accounts payable
9,715
6,787
6,274
10,165
Due to related parties-Related Party
-
-
-
228,298
Accrued expenses
28,542
22,781
7,957
6,686
Income tax payable
0
79,030
79,030
-
Deferred revenue
2,550
76,749
136,590
110,991
Note payable - related party
260,402
460,402
-
-
Total current liabilities
301,209
645,749
229,851
356,140
Series a convertible preferred stock, 1,000,000 designated, 140,000 shares issued and outstanding at june 30, 2026 and december 31, 2025
14
14
14
14
Common stock 0.0001 par value, 250,000,000 shares authorized 11,752,329 and 10,979,058 shares issued and outstanding at june 30, 2026 and december 31, 2025
1,176
1,142
1,098
1,098
Additional paid-in capital
1,948,404
1,612,234
1,175,211
1,175,211
Accumulated earnings (deficit)
-114,653
71,100
301,007
534,637
Total stockholders' equity (deficit)
1,834,941
1,684,490
1,477,330
1,710,960
Total liabilities and stockholders' equity (deficit)
2,136,150
2,330,239
1,707,181
2,067,100
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventory$797,183 (220.77%↑ Y/Y)Cash and cashequivalents$712,378 (-45.18%↓ Y/Y)Accounts receivable, net$396,899 (1.77%↑ Y/Y)Prepaid expense$40,961 (-13.46%↓ Y/Y)Income tax receivable$34,992 Operating digital assets$4,500 Intangible assets$109,845 (52.35%↑ Y/Y)Right-of-use asset$34,992 Deposits$4,400 Total current assets$1,986,913 (0.08%↑ Y/Y)Total other assets$149,237 Total assets$2,136,150 (3.83%↑ Y/Y)Total liabilities andstockholders' equity...$2,136,150 (3.83%↑ Y/Y)Total stockholders'equity (deficit)$1,834,941 (6.70%↑ Y/Y)Total currentliabilities$301,209 (-10.79%↓ Y/Y)Accumulated earnings(deficit)-$114,653 (-121.10%↓ Y/Y)Additional paid-in capital$1,948,404 (66.26%↑ Y/Y)Note payable -related party$260,402 Accrued expenses$28,542 (16.50%↑ Y/Y)Accounts payable$9,715 (-41.60%↓ Y/Y)Deferred revenue$2,550 (-98.97%↓ Y/Y)Common stock 0.0001 parvalue, 250,000,000...$1,176 (-73.22%↓ Y/Y)Series a convertiblepreferred stock,...$14 (0.00%↑ Y/Y)